Glaucoma Therapeutics Market Global Industry Analysis, Size, Share, Volume, Growth, Trends, and Forecast 2017 - 2024

Apr 2018| TMR541A| Transparency

Report Highlights

Glaucoma Therapeutics Market: Overview

Glaucoma is an ocular disease which affects the optic nerve of the iris and progression of the same results into vision loss and blindness. The treatment for glaucoma starts with topical eye drops belonging to the class of prostaglandins, beta blockers, alpha agonist, combined medication, carbonic anhydrase inhibitor and cholinergic. Administration of these eye drops reduces the production of the fluid inside eyes thereby reducing the intraocular pressure. Using topical eye drops is an alternative for surgery or delays the surgical procedure. This report analyzes the current and future prospects of the glaucoma therapeutics market based on type of drug class, end user and geography.

Glaucoma Therapeutics Market: Scope and Methodology

The research is a combination of primary and secondary research, conducted for understanding and arriving at trends, used to forecast the expected revenue of the major glaucoma therapeutics market in the near future. Primary research formed the bulk of our research efforts with information collected from in-depth interviews and discussions with a number of key industry experts and opinion leaders. Secondary research involved study of company websites, annual reports, press releases, investor presentations, analyst presentation and various international and national databases. The report provides estimated market size in terms of US$ Mn for each by drug class, end user, and geography for the period 2014 to 2024, considering the macro and micro environmental factors.

The revenue generated from each product was calculated by considering number of products used in the procedures and their market demand as per their use, number of product launched, average cost of products of each sub segment, trends in industry, end user trend, and adoption rate across all the geographies. The revenue generated for drug class was calculated on the basis of prevalence of diseases, and number of people affected by the disease

The market report comprises an elaborated executive summary, which includes market snapshot that provides information about various segments of the market. It also provides information and data analysis of the market with respect to market segments based on drug class, end-user, and geography. The market overview section of the report analyzes market dynamics such as drivers, restraints and opportunities that influences the glaucoma therapeutics market in the current and future scenario.

Based on geography, the market has been analyzed for major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. The study also covers detailed country analysis contributing majorly in the glaucoma therapeutics market.

Glaucoma Therapeutics Market: Competitive Landscape

Market share analysis among the market players is analyzed to signify the contribution of these players in the market in terms of percentage share. All these factors will help the market players to decide about the business strategies and plans to strengthen their positions in the global market. The report also profiles the major players in the market and provides various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major companies profiled in the glaucoma therapeutics market are Allergan Inc., Merck & Co., Pfizer Inc., Novartis AG., Santen Pharmaceuticals, Valeant Pharmaceuticals and Aerie Pharmaceuticals.

The glaucoma therapeutics market has been segmented as follows:

Glaucoma Therapeutics Market, by Drug Class

Alpha Agonist
Beta Blockers
Prostaglandin Analogs
Carbonic Anhydrase Inhibitor
Cholinergic
Combined Medication
Glaucoma Therapeutics Market, by End Users

Ophthalmic clinic
Hospitals
Ambulatory Surgical Centers
Glaucoma Therapeutics Market, by Geography

North America
U.S.
Canada
Latin America
Brazil
Mexico
Rest of Latin America
Europe
U.K.
Germany
Spain
Italy
France
Rest of Europe
Asia Pacific
India
Japan
China
Australia
New Zealand
Rest of Asia Pacific
Middle East and Africa
South Africa
Saudi Arabia
A.E.
Rest of MEA

  • Table 1 : Global Glaucoma Therapeutics Market Size (US$ Mn) Forecast, by Drug Class, 2014–2024
  • Table 2 : Global Glaucoma Therapeutics Market Size (US$ Mn) Forecast, by End-user, 2014–2024
  • Table 3 : Global Glaucoma Therapeutics Market Size (US$ Mn) Forecast, by Region, 2014–2024
  • Table 4 : North America Glaucoma Therapeutics Market Size (US$ Mn) Forecast, by Drug Class, 2014–2024
  • Table 5 : North America Glaucoma Therapeutics Market Forecast, by End-user, 2014–2024
  • Table 6 : North America Glaucoma Therapeutics Market Size (US$ Mn) Forecast, by Country, 2014–2024
  • Table 7 : Europe Glaucoma Therapeutics Market Size (US$ Mn) Forecast, by Drug Class, 2014–2024
  • Table 8 : Europe Glaucoma Therapeutics Market Forecast, by End-user, 2014–2024
  • Table 9 : Europe Glaucoma Therapeutics Market Size (US$ Mn) Forecast, by Country, 2014–2024
  • Table 10 : Asia Pacific Glaucoma Therapeutics Market Size (US$ Mn) Forecast, by Drug Class, 2014–2024
  • Table 11 : Asia Pacific Glaucoma Therapeutics Market Forecast, by End-user, 2014–2024
  • Table 12 : Asia Pacific Glaucoma Therapeutics Market Size (US$ Mn) Forecast, by Country, 2014–2024
  • Table 14 : Latin America Glaucoma Therapeutics Market Size (US$ Mn) Forecast, by Drug Class, 2014–2024
  • Table 15 : Latin America Glaucoma Therapeutics Market Forecast, by End-user, 2014–2024
  • Table 16 : Latin America Glaucoma Therapeutics Market Size (US$ Mn) Forecast, by Country, 2014–2024
  • Table 17 : Middle East & Africa Glaucoma Therapeutics Market Size (US$ Mn) Forecast, by Drug Class, 2014–2024
  • Table 18 : Middle East & Africa Glaucoma Therapeutics Market Forecast, by End-user, 2014–2024
  • Table 19 : Middle East & Africa Glaucoma Therapeutics Market Size (US$ Mn) Forecast, by Country, 2014–2024
  • Figure 1 : Market Value Share, by Drug Class (2016) Revenue (US$ Mn)
  • Figure 2 : Market Value Share, by End-user (2016) Revenue (US$ Mn)
  • Figure 3 : Market Value Share, by Region (2016) Revenue (US$ Mn)
  • Figure 4 : Global Glaucoma Therapeutics Market Value Share Analysis, by Drug Class, 2015 and 2024
  • Figure 5 : Global Prostaglandins Market Revenue (US$ Mn), 2014–2024
  • Figure 6 : Global Beta Blockers Market Revenue (US$ Mn), 2014–2024
  • Figure 7 : Global Alpha Agonist Market, Revenue (US$ Mn), 2014–2024
  • Figure 8 : Global Carbonic Anhydrase Inhibitor Market, Revenue (US$ Mn), 2014–2024
  • Figure 9 : Global Combined Medication Market, Revenue (US$ Mn), 2014–2024
  • Figure 10 : Global Cholinergic Market, Revenue (US$ Mn), 2014–2024
  • Figure 11 : Glaucoma Therapeutics Market Attractiveness Analysis, by Drug Class, 2015
  • Figure 12 : Global Glaucoma Therapeutics Market Value Share Analysis, by End-user, 2015 and 2024
  • Figure 13 : Global Hospital Market Revenue (US$ Mn), 2014–2024
  • Figure 14 : Global Ophthalmic Clinics Market Revenue (US$ Mn), 2014–2024
  • Figure 15 : Global Ambulatory Surgical Centers Market Revenue (US$ Mn), 2014–2024
  • Figure 16 : Glaucoma Therapeutics Market Attractiveness Analysis, by End-user, 2015
  • Figure 17 : Global Glaucoma Therapeutics Market Value Share Analysis, by Region, 2015 and 2024
  • Figure 18 : Glaucoma Therapeutics Market Attractiveness Analysis, by Region, 2015
  • Figure 19 : North America Glaucoma Therapeutics Market Size (US$ Mn) Forecast, 2014–2024
  • Figure 20 : North America Glaucoma Therapeutics Market Attractiveness Analysis, by Country, 2015
  • Figure 21 : North America Glaucoma Therapeutics Market Value Share Analysis, by Drug Class, 2015 and 2024
  • Figure 22 : North America Glaucoma Therapeutics Market Value Share Analysis, by End-user, 2015 and 2024
  • Figure 23 : North America Glaucoma Therapeutics Market by Country, 2015 and 2024
  • Figure 24 : North America Glaucoma Therapeutics Market Attractiveness Analysis, by Drug Class, 2015
  • Figure 25 : North America Glaucoma Therapeutics Market Attractiveness Analysis, by End User, 2015
  • Figure 26 : Europe Glaucoma Therapeutics Market Size (US$ Mn) Forecast, 2015–2024
  • Figure 27 : Europe Glaucoma Therapeutics Market Attractiveness Analysis, by Country, 2015
  • Figure 28 : Europe Glaucoma Therapeutics Market Value Share Analysis, by Drug Class, 2015 and 2024
  • Figure 29 : Europe Glaucoma Therapeutics Market Value Share Analysis, by End-user, 2015 and 2024
  • Figure 30 : Europe Glaucoma Therapeutics Market by Country, 2015 and 2024
  • Figure 31 : Europe Glaucoma Therapeutics Market Attractiveness Analysis, by Drug Class, 2015
  • Figure 32 : Europe Glaucoma Therapeutics Market Attractiveness Analysis, by End-user, 2015
  • Figure 33 : Asia Pacific Glaucoma Therapeutics Market Size (US$ Mn) Forecast, 2014–2024
  • Figure 34 : Asia Pacific Glaucoma Therapeutics Market Attractiveness Analysis, by Country, 2015
  • Figure 35 : Asia Pacific Glaucoma Therapeutics Market Value Share Analysis, by Drug Class, 2015 and 2024
  • Figure 36 : Asia Pacific Glaucoma Therapeutics Market Value Share Analysis, by End-user, 2015 and 2024
  • Figure 37 : Asia Pacific Glaucoma Therapeutics Market by Country, 2015 and 2024
  • Figure 38 : Asia Pacific Glaucoma Therapeutics Market Attractiveness Analysis, by Drug Class, 2015
  • Figure 39 : Asia Pacific Glaucoma Therapeutics Market Attractiveness Analysis, by End User, 2015
  • Figure 40 : Latin America Glaucoma Therapeutics Market Size (US$ Mn) Forecast, 2014–2024
  • Figure 41 : Latin America Glaucoma Therapeutics Market Attractiveness Analysis, by Country, 2015
  • Figure 42 : Latin America Glaucoma Therapeutics Market Value Share Analysis, by Drug Class, 2015 and 2024
  • Figure 43 : Latin America Glaucoma Therapeutics Market Value Share Analysis, by End-user, 2015 and 2024
  • Figure 44 : North America Glaucoma Therapeutics Market by Country, 2015 and 2024
  • Figure 45 : Latin America Glaucoma Therapeutics Market Attractiveness Analysis, by Drug Class, 2015
  • Figure 46 : Latin America Glaucoma Therapeutics Market Attractiveness Analysis, by End-user, 2015
  • Figure 47 : Middle East & Africa Glaucoma Therapeutics Market Size (US$ Mn) Forecast, 2015–2024
  • Figure 48 : Middle East & Africa Glaucoma Therapeutics Market Attractiveness Analysis, by Country, 2015
  • Figure 49 : Middle East & Africa Glaucoma Therapeutics Market Value Share Analysis, by Drug Class, 2015 and 2024
  • Figure 50 : Middle East & Africa Glaucoma Therapeutics Market Value Share Analysis, by End-user, 2015 and 2024
  • Figure 51 : Middle East & Africa Glaucoma Therapeutics Market by Country, 2015 and 2024
  • Figure 52 : Middle East & Africa Glaucoma Therapeutics Market Attractiveness Analysis, by Drug Class, 2015
  • Figure 53 : Middle East & Africa Glaucoma Therapeutics Market Attractiveness Analysis, by End-user, 2015
  • Figure 54 : Global Glaucoma Therapeutics Market Share Analysis, by Company (2015)

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report